Business

Glenmark gets tentative nod from USFDA for generic multiple sclerosis treatment drug

Glenmark gets tentative nod from USFDA for generic multiple sclerosis treatment drug The tentative nod granted by US Food Drug Administration (USFDA) to Glenmark Pharmaceuticals Inc, USA (Glenmark) is for multiple strengths of dimethyl fumarate delayed-release capsules of 120 mg and 240 mg.

from Moneycontrol Business News
Read The Rest:moneycontrol...

Realted Posts